On Nov. 1, BioMarin Pharmaceutical (NASDAQ:BMRN) released third-quarter earnings for the period ended Sept. 30.

  • Revenues beat the estimates by 11.2%, while EPS topped the consensus estimate with a loss of $0.08.

  • Revenue increases were mainly due to stronger product sales, particularly in Aldurazyme and Naglazyme.

  • Restrained spending and top-line growth let to a significant movement toward profitability.

  • Get our full Foolish Take on BioMarin's latest quarter.

(Figures in thousands, except per-share data)

Income Statement Highlights

Avg. Est.

Q3 2006

Q3 2005

Change

Sales

$19,716

$24,927

$7,579

228.9%

Net Profit*

--

($7,036)

($15,476)

N/A

EPS

($0.12)

($0.08)

($0.21)

N/A

Diluted Shares

--

86,269

71,996

19.8%



Get back to basics with a look at the income statement.

Margin Checkup

Q3 2006

Q3 2005

Change*

Gross Margin

89.52%

97.84%

(8.32)

Operating Margin

(16.51%)

(173.82%)

157.31

Net Margin

(28.23%)

(204.20%)

175.97

*Expressed in percentage points.

Margins are the earnings engine. See how they work.

Balance Sheet Highlights

Assets

Q3 2006

Q3 2005

Change

Cash + ST Invest.

$293.9

$65.9

346%

Accounts Rec.

$13.0

$5.3

145.3%

Inventory

$25.8

$7.7

235.1%


Liabilities

Q3 2006

Q3 2005

Change

Accounts Payable*

$29.2

$22.9

27.5%

Long-Term Debt

$293.1

$214.4

36.7%

*Includes accrued liabilities.

Learn the ways of the balance sheet.

Cash Flow Highlights

A statement of cash flows was not provided.

Find out why Fools always follow the money.

Related Companies:

  • Medarex (NASDAQ:MEDX)
  • Crucell NV (NASDAQ:CRXL)
  • Regeneron Pharmaceuticals (NASDAQ:REGN)
  • ZymoGenetics (NASDAQ:ZGEN)

Related Foolishness:

Get the latest updates from the fast-paced world of biotech, and other spawning grounds for amazing growth stocks, with a free 30-day trial to Motley Fool Rule Breakers.

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.